Related Experiment Videos
Hybrid polypeptide heavy chains produced by two hybridoma lines
Molecular Immunology
|January 1, 1987
Summary
Researchers discovered two unique anti-TNP antibodies in hybridomas CBT3 and CBT4. These antibodies suggest novel heavy chain production mechanisms involving gamma 3, gamma 2b, and mu genes.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Hybridoma technology is crucial for producing monoclonal antibodies.
- Antibody isotype switching involves complex genetic rearrangements.
Purpose of the Study:
- To characterize two novel anti-trinitrophenyl (TNP) hybridomas with unusual antibody properties.
- To investigate the molecular basis for the production of unique antibody heavy chains.
Main Methods:
- Spleen cells from immunized mice were fused with SP2/0 myeloma cells.
- Hybridoma supernatants were analyzed for antibody reactivity using anti-isotypic sera.
- Immunoglobulin secretion patterns were assessed to rule out hybrid molecules.
Main Results:
- Hybridoma CBT3 secretes antibodies reactive with both anti-gamma 2b and anti-gamma 3 sera.
- Hybridoma CBT4 secretes antibodies reactive with both anti-mu and anti-gamma 2b sera.
- Each hybridoma produces only one immunoglobulin type, excluding hybrid molecules.
Conclusions:
- The findings suggest that unique heavy chains are produced by combining elements from different immunoglobulin heavy chain genes.
- Hybridoma CBT3 likely produces heavy chains derived from gamma 3 and gamma 2b genes.
- Hybridoma CBT4 likely produces heavy chains derived from gamma 2b and mu genes, indicating novel molecular mechanisms.